EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.13.11.33 | 2-(4-ethylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 2-(4-methylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 2-(4-methylpiperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 2-(morpholin-4-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 2-(piperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 2-(pyrrolidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 4-methyl-2-(4-ethylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 4-methyl-2-(4-methylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 4-methyl-2-(4-methylpiperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 4-methyl-2-(morpholin-4-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 4-methyl-2-(piperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | 4-methyl-2-(pyrrolidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | - |
Glycine max | |
1.13.11.33 | additional information | docking experiments and structure activity relationship, comparative studies, comparison with the crystal structure with PDB entry: 1IK3, EC 1.13.11.12, overview | Glycine max |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.11.33 | Glycine max | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.11.33 | linoleic acid + O2 | - |
Glycine max | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.13.11.33 | 15-lipoxygenase | - |
Glycine max |
1.13.11.33 | 15-LO | - |
Glycine max |
1.13.11.33 | More | cf. EC 1.13.11.12 | Glycine max |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.13.11.33 | 20 | - |
assay at | Glycine max |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.13.11.33 | 9 | - |
assay at | Glycine max |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.13.11.33 | additional information | - |
additional information | docking experiments and structure activity relationship comparative studies, estimated inhibition constants, calculated in autodock, overview | Glycine max |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.13.11.33 | 0.018 | - |
pH 9.0, 20°C | Glycine max | 4-methyl-2-(4-methylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.036 | - |
pH 9.0, 20°C | Glycine max | 4-methyl-2-(4-ethylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.048 | - |
pH 9.0, 20°C | Glycine max | 4-methyl-2-(pyrrolidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.058 | - |
pH 9.0, 20°C | Glycine max | 4-methyl-2-(piperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.058 | - |
pH 9.0, 20°C | Glycine max | 4-methyl-2-(morpholin-4-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.076 | - |
pH 9.0, 20°C | Glycine max | 4-methyl-2-(4-methylpiperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.14 | - |
pH 9.0, 20°C | Glycine max | 2-(morpholin-4-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.146 | - |
pH 9.0, 20°C | Glycine max | 2-(piperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.18 | - |
pH 9.0, 20°C | Glycine max | 2-(4-methylpiperidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.216 | - |
pH 9.0, 20°C | Glycine max | 2-(pyrrolidin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.235 | - |
pH 9.0, 20°C | Glycine max | 2-(4-ethylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine | |
1.13.11.33 | 0.267 | - |
pH 9.0, 20°C | Glycine max | 2-(4-methylpiperazin-1-yl)pyrimido[4,5-b][1,4]benzothiazine |